Arylamine N-acetyltransferase-1 reveals a subpopulation of ALS patients with altered metabolic capacity https://www.biorxiv.org/content/10.1101/2023.06.29.546993v1?med=mas
CleverLibre Social is an inclusive social instance for open discussion, learning, and community. All cultures welcome. Hate speech and harassment strictly forbidden.